Xenon Pharmaceuticals Inc (XENE)
Sales/Maturities of Investments
$708.46M
TTM · Period ending: · USD
XENE Sales/Maturities of Investments
Latest reported$708.46Mperiod ending
Latest reported$708.46Mperiod ending
XENE TTM Sales/Maturities of Investments ($6.55M → $708.46M)
TTM Sales/Maturities of Investments
High-resolution chart · PNG
XENE sales/maturities of investments history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 708,461,000 | |
| 720,275,000 | |
| 787,564,000 | |
| 616,179,000 | |
| 667,841,000 | |
| 733,819,000 | |
| 701,870,000 | |
| 673,170,000 | |
| 703,991,000 | |
| 659,087,000 | |
| 682,354,000 | |
| 647,575,000 | |
| 512,622,000 | |
| 394,858,000 | |
| 258,028,000 | |
| 198,142,000 | |
| 162,897,000 | |
| 119,079,000 | |
| 144,754,000 | |
| 161,843,000 | |
| 189,231,354 | |
| 207,558,006 | |
| 216,807,006 | |
| 162,202,006 | |
| 128,696,652 | |
| 103,019,000 | |
| 75,443,000 | |
| 85,170,000 | |
| 74,378,000 | |
| 62,844,000 | |
| 48,522,000 | |
| 45,628,000 | |
| 36,663,000 | |
| 56,538,000 | |
| 52,616,000 | |
| 41,024,000 | |
| 41,099,000 | |
| 9,384,000 | |
| 0 | |
| -10,745,000 | |
| -1,818,000 | |
| -1,575,000 | |
| 0 | |
| 12,481,000 | |
| 10,789,000 | |
| 12,394,000 | |
| 13,539,000 | |
| 18,353,000 | |
| 11,118,000 | |
| 9,270,000 | |
| 6,550,000 | |
| 0 | |
| 0 |